LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5
Cancer Biomarkers · 2023
DOI: 10.3233/cbm-220223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, 2023. Verfasst von Zhiqiang Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracardiac Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Adenocarcinoma of Lung, Antigens, CD. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: It has been discovered that lncRNA ARAP1-AS1 is upregulated and operates as a tumor promoter in many cancers. However, its pattern of expression and potential mechanism in lung adenocarcinoma (LUAD) is still unknown. METHODS: The levels of lncRNA ARAP1-AS1, miR-8068, and CEACAM5 expressions in LUAD cell lines and tissues were assessed by conducting western blot and RT-qPCR analyses. MiR-8068’s potential targeting relationships with lncRNA ARAP1-AS1 and CEACAM5 were ascertained by performing bioinformatics analysis. The interaction of lncRNA ARAP1-AS1 with miR-8068 was validated by means of by RIP and luciferase reporter experiments. CCK-8, cell adhesion, and Transwell migration experiments were conducted to study how lncRNA ARAP1-AS1 affects LUAD cell migration, adhesion, and proliferation. To confirm the function of lncRNA ARAP1-AS1 in vivo, a tumor formation experiment was executed. RESULTS: An elevated expression of lncRNA ARAP1-AS1 was observed among the LUAD cells and tissues. The overexpression of lncRNA ARAP1-AS boosted cell proliferation, adhesion, and migration in LUAD and also favored in vivo tumor growth. MiR-8068 was found to be lncRNA ARAP1-AS1’s target gene. MiR-8068 overexpression partially antagonized lncRNA ARAP1-AS1’s promotive effect on proliferation, viability, and adhesion. Meanwhile CEACAM5 could alleviate the miR-8068-induced inhibition of tumor growth. The negative correlation of miR-8068 with lncRNA ARAP1-AS1 or CEACAM5 was also revealed. CONCLUSION: To upregulate CEACAM5 expression lncRNA ARAP1-AS1 targeted miR-8068, thus promoting the progression of LUAD. This indicates that the lncRNA ARAP1-AS1/miR-8068/CEACAM5 axis has potential as a therapeutic target in LUAD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracardiac Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
- Department of Thoracic surgery, Ya'an City Second People's Hospital, Ya'an, Sichuan, China.
Zitieren
APA
Wu, Z., Zeng, X., Wang, H., & Wang, X. (2023). LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5. Cancer Biomarkers. https://doi.org/10.3233/cbm-220223
Vancouver
Wu Z, Zeng X, Wang H, Wang X. LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5. Cancer Biomarkers. 2023. doi:10.3233/cbm-220223
BibTeX
@article{Wu2023,
author = {Wu, Zhiqiang and Zeng, Xiaofei and Wang, Hong and Wang, Xianbo},
title = {LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5},
journal = {Cancer Biomarkers},
year = {2023},
doi = {10.3233/cbm-220223}
}
EUVIMED